V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160015091 | 160020095 | 1.81 | null | Neo-adjuvant (N) | 2019-02-14 | 2019-02-22 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN | 100361432 |
| 160015137 | 160020096 | 1.63 | 70 | null | 2019-06-27 | 2019-07-10 | Bevacizumab | null | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101854820 |
| 160015167 | 160020098 | 1.67 | 55.1 | Palliative (P) | 2018-08-24 | 2018-08-25 | Liposomal Doxorubicin 50mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 100548178 |
| 160015278 | 160020099 | 1.6 | 63 | Palliative (P) | 2020-03-04 | 2020-03-12 | Bevacizumab | N | N | PACLITAXEL | 100252141 |
| 160015290 | 160020100 | 1.7 | 101.3 | Curative (C) | 2017-07-18 | 2017-07-19 | Bevacizumab | N | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101658935 |
| 160015343 | 160020101 | 1.63 | 62.4 | Palliative (P) | 2020-08-24 | 2020-11-28 | Bevacizumab | 02 | N | CARBOPLATIN | 100568238 |
| 160015378 | 160020102 | 1.5 | 70.5 | Palliative (P) | 2018-12-16 | 2018-12-17 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100356244 |
| 160015420 | 160020103 | 1.92 | 44.9 | Palliative (P) | 2020-08-28 | 2020-09-03 | Bevacizumab | 02 | N | BEVACIZUMAB | 101071981 |
| 160015442 | 160020104 | 1.69 | 57.5 | Palliative (P) | 2018-06-23 | 2020-04-01 | Bevacizumab 7.5mg/kg | 02 | N | DOXORUBICIN + OLARATUMAB | 100059880 |
| 160015449 | 160020105 | 1.71 | null | Palliative (P) | null | null | Carboplatin + Paclitaxel (3 weekly) | 99 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101614057 |
| 160015470 | 160020106 | 0.02 | 59.5 | Palliative (P) | 2017-04-12 | 2017-06-01 | DOCETAXEL + GEMCITABINE | 02 | N | CARBOPLATIN | 100866674 |
| 160015519 | 160020108 | 1.46 | 82.9 | Palliative (P) | 2017-06-19 | 2021-05-08 | DOCETAXEL + GEMCITABINE | 01 | null | DOCETAXEL + GEMCITABINE | 100116048 |
| 160015528 | 160020109 | 1.71 | 75 | null | 2016-11-01 | 2016-12-03 | Liposomal Doxorubicin (Caelyx) | 02 | null | CISPLATIN + PEMETREXED | 101653921 |
| 160015535 | 160020110 | 1.69 | 78.6 | Palliative (P) | 2019-09-24 | 2019-10-08 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101424685 |
| 160015545 | 160020111 | 1.81 | 68.9 | null | 2017-07-15 | 2017-07-16 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 101403798 |
| 160015570 | 160020112 | 1.71 | 79.8 | Palliative (P) | 2020-04-08 | 2020-04-20 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100897573 |
| 160015595 | 160020113 | 1.63 | 57.4 | null | 2018-06-01 | 2018-06-03 | Liposomal Doxorubicin (Caelyx) | 02 | null | PACLITAXEL | 100668641 |
| 160015600 | 160020114 | 1.71 | 62.9 | null | 2021-11-27 | 2022-01-10 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101463599 |
| 160015651 | 160020115 | 1.71 | 122.1 | Palliative (P) | 2021-07-05 | 2021-07-18 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101700481 |
| 160015679 | 160020116 | null | 61.9 | Palliative (P) | 2019-06-13 | 2019-08-13 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN | 100494943 |
| 160015739 | 160020117 | 1.69 | 55.4 | Palliative (P) | 2020-01-13 | 2020-01-22 | Bevacizumab 7.5mg/kg | 02 | N | PACLITAXEL | 100125940 |
| 160015750 | 160020118 | 1.86 | 50 | null | 2018-09-25 | 2018-09-30 | Bevacizumab 7.5mg/kg | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101263802 |
| 160015775 | 160020119 | 1.8 | 59.65 | null | 2021-05-12 | 2021-05-13 | CARBOPLATIN + PACLITAXEL | 02 | null | PACLITAXEL | 101406357 |
| 160015807 | 160020120 | 1.49 | 98 | null | 2021-01-06 | 2021-01-18 | Bevacizumab | 02 | null | CARBOPLATIN + PACLITAXEL | 100864853 |
| 160015809 | 160020121 | 1.62 | 93.8 | Disease modification (D) | 2020-10-22 | 2020-10-24 | Bevacizumab 7.5mg/kg | 02 | N | PACLITAXEL | 100276551 |
| 160015810 | 160020122 | 1.51 | 57 | Palliative (P) | 2020-04-02 | 2020-04-02 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101421285 |
| 160015890 | 160020124 | 1.73 | 119.2 | Neo-adjuvant (N) | 2018-12-27 | 2019-03-26 | Liposomal Doxorubicin (Caelyx) | N | null | LIPOSOMAL DOXORUBICIN | 100523382 |
| 160015916 | 160020126 | 1.79 | 72.7 | Palliative (P) | 2017-09-21 | 2017-10-02 | Doxorubicin + Olaratumab | 02 | N | DOXORUBICIN + OLARATUMAB | 101853045 |
| 160015952 | 160020127 | 1.46 | 55.2 | Palliative (P) | 2019-09-12 | 2019-09-23 | Bevacizumab 7.5mg/kg | 02 | N | BEVACIZUMAB | 100137761 |
| 160015969 | 160020128 | 1.66 | 74.75 | Palliative (P) | 2018-09-10 | 2018-09-24 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101127652 |
| 160015971 | 160020129 | 1.67 | 57 | Palliative (P) | 2018-08-20 | 2018-09-18 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + PACLITAXEL | 101396540 |
| 160016038 | 160020130 | 1.77 | 103.65 | Palliative (P) | 2019-09-18 | 2019-09-23 | Bevacizumab | 02 | N | CARBOPLATIN + GEMCITABINE | 101849043 |
| 160016071 | 160020131 | 1.75 | 83.5 | null | 2019-12-12 | 2019-12-27 | Bevacizumab 7.5mg/kg | 2 | null | CARBOPLATIN | 101610285 |
| 160016154 | 160020132 | 1.69 | 65.8 | Palliative (P) | 2019-10-15 | 2019-10-17 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100806339 |
| 160016183 | 160020133 | 1.68 | 56.8 | null | 2018-02-16 | 2018-02-24 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 100705666 |
| 160016208 | 160020134 | 1.51 | 72.9 | Palliative (P) | 2021-12-29 | 2022-01-08 | PACLITAXEL | N | N | PACLITAXEL | 101453452 |
| 160016215 | 160020135 | 1.73 | 73.9 | Palliative (P) | 2018-08-23 | 2018-08-30 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101711099 |
| 160016287 | 160020137 | 1.76 | 46.7 | Disease modification (D) | 2018-09-26 | 2018-10-15 | Bevacizumab | 02 | N | DOXORUBICIN + OLARATUMAB | 101210219 |
| 160016304 | 160020138 | 1.74 | 59 | Neo-adjuvant (N) | 2018-09-06 | 2018-09-09 | Bevacizumab 7.5mg/kg | 02 | N | CISPLATIN + PEMETREXED | 100017071 |
| 160016308 | 160020139 | 1.68 | 82.15 | null | 2020-01-04 | 2020-01-13 | Liposomal Doxorubicin 50mg/m2 | 02 | null | LIPOSOMAL DOXORUBICIN | 101681747 |
| 160016323 | 160020140 | 1.52 | 62 | Palliative (P) | 2021-07-14 | 2021-07-17 | Bevacizumab | 02 | N | PACLITAXEL | 101402071 |
| 160016345 | 160020141 | 1.77 | 72 | Neo-adjuvant (N) | 2020-06-24 | 2020-06-24 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100784492 |
| 160016348 | 160020142 | 1.79 | 81.4 | null | 2018-04-28 | 2018-05-17 | Bevacizumab 7.5mg/kg | 02 | N | PACLITAXEL | 100954658 |
| 160016366 | 160020143 | 1.5 | 59.8 | null | 2020-03-28 | 2020-04-03 | PACLITAXEL | N | null | PACLITAXEL | 101311932 |
| 160016409 | 160020144 | 1.54 | 55 | Neo-adjuvant (N) | 2019-08-18 | 2019-08-18 | PACLITAXEL | 02 | N | PACLITAXEL | 101579720 |
| 160016429 | 160020145 | 1.74 | 48.6 | Palliative (P) | 2017-08-26 | 2017-08-27 | Doxorubicin + Olaratumab | 2 | N | DOXORUBICIN + OLARATUMAB | 100736808 |
| 160016440 | 160020146 | 1.6 | 72.4 | Palliative (P) | 2018-09-04 | 2019-04-29 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100907107 |
| 160016447 | 160020147 | 1.79 | 50.8 | Curative (C) | 2021-02-26 | 2021-03-10 | ETOP 13-18 BEAT-meso Trial | 02 | N | ETOPOSIDE | 101003237 |
| 160016479 | 160020148 | 1.82 | 79.8 | null | 2019-08-07 | 2019-08-30 | Bortezomib + Daratumumab | null | null | PEMBROLIZUMAB | 100294636 |
| 160016488 | 160020149 | 1.7 | 73.6 | 03 | 2018-03-30 | 2018-08-15 | Eribulin | 01 | N | OLARATUMAB | 100949605 |